cor2ed
engage checkpoint medical linkedin twitter
bg

Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Asia-Pacific)

Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Asia-Pacific)

Prof. Pierce KH Chow

View this summary of the July 2020 HCC Experts Round Table meeting (Asia-Pacific) and download the accompanying educational slide set for more information.
Portrait of Pierce KH Chow
Prof. Pierce KH Chow

Liver Surgeon

National Cancer Center Singapore

Singapore

preview next

time Video | open 5 min | Jul 2020

I agree that this educational programme:

 

The HCC Experts Round Table (Asia-Pacific) brought together international experts in hepatocellular carcinoma. This interdisciplinary group (oncology, surgical oncology, hepatology, patient advocacy, and health economics) explored evolving standards of care for advanced first-line HCC, particularly in light of IMbrave150 phase III clinical trial data. Follow the link above to view the recent publication announcement from the HCC Experts Round Table.

Other programmes of interest